Seeking Alpha

PVCT
Provectus Biopharmaceuticals, Inc. - OTCQB

4/17/2014, 5:54 AM ET
Quote & Analysis Breaking News StockTalk
pvct chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PVCT vs. ETF Alternatives
Company Description

Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology... More

OTHER NEWS